ALKERMES reported $136.08M in Stock for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Acadia Pharmaceuticals ACAD:US $ 10.79M 0.48M
Amgen AMGN:US $ 4115M 98M
Biogen BIIB:US $ 1347.9M 93.1M
Biomarin Pharmaceutical BMRN:US $ 710.98M 2.95M
Bluebird Bio BLUE:US $ 13.5M 4.58M
Bristol Myers Squibb BMY:US $ 2137M 184M
Coherus Biosciences CHRS:US $ 96.08M 44.47M
Eli Lilly And LLY:US $ 3824.9M 164.1M
Gilead Sciences GILD:US $ 2988M 8M
H. Lundbeck A/S LUN:DC 2.6B 14M
Heron Therapeutics HRTX:US $ 42.8M 0.17M
Horizon Pharma HZNP:US $ 258.68M 20.37M
IONIS PHARMACEUT IONS:US $ 24.1M 1.9M
Nektar Therapeutics NKTR:US $ 14.62M 2.19M
Neurocrine Biosciences NBIX:US $ 28.3M 1.8M
Otsuka Holdings 4578:JP Y 182052M 756M
Regeneron Pharmaceuticals REGN:US $ 1983.9M 318.6M
Vertex Pharmaceuticals VRTX:US $ 321.62M 22.76M
Zogenix ZGNX:US $ 2.92M 0.6M